1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Gastroduodenal Ulcer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogiwara, T; Sato, N | 1 |
| Jewell, DP; Travis, SP | 1 |
| Gebert, U; Morioka, Y; Tanaka, T | 1 |
| Rainsford, KD | 1 |
| Polonskiĭ, VM | 1 |
| Esplugues, JV; Whittle, BJ | 1 |
| Cucala, M; Guarner, F; Malagelada, JR; Rodríguez, R; Salas, A; Wallace, JL | 1 |
| Lagente, V; Steel, G; Vargaftig, B; Wallace, JL; Whittle, BJ | 1 |
| Wallace, JL; Whittle, BJ | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Gastroduodenal Ulcer
| Article | Year |
|---|---|
[Stress and etiology of peptic ulcers].
Topics: Endothelins; Gastric Mucosa; Heat-Shock Proteins; Humans; Leukotrienes; Microcirculation; Peptic Ulcer; Platelet Activating Factor; Stress, Physiological | 1995 |
The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
Topics: Adjuvants, Immunologic; Animals; Cholestasis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Digestive System Physiological Phenomena; Enterocolitis, Pseudomembranous; Epithelium; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypertension, Portal; Ischemia; Microcirculation; Pancreatitis; Peptic Ulcer; Platelet Activating Factor | 1994 |
[Platelet activating factor as a mediator of lesions of the digestive system].
Topics: Animals; Colitis, Ulcerative; Disease Models, Animal; Humans; Liver Cirrhosis, Experimental; Pancreatitis; Peptic Ulcer; Platelet Activating Factor; Rats | 1990 |
Gastric effects of PAF.
Topics: Animals; Gastric Mucosa; Peptic Ulcer; Platelet Activating Factor | 1989 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Effect of a novel xanthine derivative on experimental ulcers in rats.
Topics: Ammonium Hydroxide; Animals; Anti-Ulcer Agents; Cold Temperature; Cysteamine; Duodenal Ulcer; Ethanol; Hydroxides; Immersion; Male; Peptic Ulcer; Peptic Ulcer Hemorrhage; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological; Xanthines | 1993 |
Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arthritis; Arthritis, Experimental; Calcium; Cholinergic Agents; Female; Leukotriene Antagonists; Leukotriene B4; Male; Mice; Peptic Ulcer; Platelet Activating Factor; Rats; Thiocholine | 1999 |
CNS effects of platelet-activating factor on the rat stomach.
Topics: Animals; Brain; Gastric Acid; Gastric Mucosa; Injections, Intraventricular; Peptic Ulcer; Platelet Activating Factor; Rats; Stomach | 1989 |
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Topics: Animals; Blood Pressure; Disease Models, Animal; Diterpenes; Escherichia coli Infections; Ethanol; Ginkgolides; Glyceryl Ethers; Intestine, Small; Lactones; Lipopolysaccharides; Male; Peptic Ulcer; Peptic Ulcer Hemorrhage; Phospholipid Ethers; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock, Septic; Stomach; Thiazoles | 1987 |
Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.
Topics: Animals; Blood Pressure; Endotoxins; Lipopolysaccharides; Male; Peptic Ulcer; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salmonella typhi; Thiazoles | 1986 |